PharmaTher Announces FDA Approval of Ketamine IND In The Treatment of Parkinson’s Disease May 17, 2021
PsyBio Therapeutics Increases Intellectual Property Portfolio with Filing of Novel Genetic Optimization Pathways for… May 12, 2021
PharmaDrug Initiates Preclinical Study of Cepharanthine to Both Broaden Its Cancer Scope and to Streamline Its Strategy… May 6, 2021
Mountain Valley MD Proceeding With Pre-Clinical Cancer Trials, Files Related Cancer Paten May 3, 2021
PsyBio and Miami University Broaden Partnership Agreement to Continued Advancement of its Neuropsychiatric Drug… Apr 26, 2021